# Nourish

> Nourish is a U.S. virtual nutrition and metabolic care company that connects people with registered dietitians, bills participating insurance plans and supports patients through an app. Its expanding clinic adds labs, medication management and medical care according to patient need.

- **Founded:** 2021
- **Headquarters:** New York, United States
- **Founders:** Aidan Dewar (Co-founder and CEO), Sam Perkins (Co-founder, President and COO), Stephanie Liu (Co-founder and CTO)
- **Products:** Virtual registered dietitian care, Nourish app, Metabolic health clinic, Provider AI copilots, Clinical Outcomes Model
- **Notable:** Company-reported total funding of $215 million as of May 19, 2026., Company reports 10,000+ registered dietitians and nationwide availability., Company reports 500,000+ people helped.

## Products & services

- **Virtual registered dietitian care** — Insurance-covered telehealth nutrition counseling and medical nutrition therapy, matched to patient conditions and preferences.
- **Nourish app** — Dietitian messaging, appointment management, AI meal logging, recipes, goals, health tracking and claim status; available on iOS, Android and web.
- **Metabolic health clinic** — Dietitian-led care with lab testing, physician care and GLP-1 prescribing and medication management layered in according to eligibility and need; expansion announced in 2026.
- **Provider AI copilots** — Administrative automation, clinical notes and insights to support clinicians.
- **Clinical Outcomes Model** — Clinical coaching, care pathways, product evaluation and longitudinal data; enables partnership models tying fees to patient outcomes.

## Achievements

- Company-reported total funding of $215 million as of May 19, 2026.
- Company reports 10,000+ registered dietitians and nationwide availability.
- Company reports 500,000+ people helped.
- Inc. 5000 rank No. 39 in 2026, with 6,794% reported three-year growth.
- CEO told Fierce Healthcare that Nourish became profitable in 2025; not independently audited here.

## Latest updates

- **2026-10** — October 1 company whitepaper announcement examined 7,675 patients on semaglutide or tirzepatide and reported 76% medication persistence at six months compared with a 46% external benchmark; observational comparison.
- **2026-08** — Listed at No. 39 on the 2026 Inc. 5000.
- **2026-06** — June 30 announcement introduced the Clinical Outcomes Model and outcomes-based partnership fees.
- **2026-06** — June 2 company analysis associated six or more dietitian appointments with 2.3 times greater six-month weight loss than one or two visits among high-acuity patients.
- **2026-05** — Announced $100 million Series C led by Menlo Ventures and expansion of dietitian-led metabolic care.

## Links

- Website: https://www.nourish.com/
- LinkedIn: https://www.linkedin.com/company/nourish/
- Instagram: https://www.instagram.com/usenourish/
- Facebook: https://www.facebook.com/usenourish/
- TikTok: https://www.tiktok.com/@nourish

---

Profile page: https://yespress.io/nourish
Published by YesPress — https://yespress.io
Last updated: 2026-10-03